ImmuCell Corporation share price logo

ImmuCell Corporation

NASDAQ: ICCC

Small Cap

$8.86

+0.14

(+1.61%)

as on

ImmuCell Corporation Stock Performance

as on May 6, 2026 at 6:56 am IST

  • Day's Low

    Day's High

    $8.72
    $8.96
    downward going graph

    1.58%

    Downside

    1.13%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.52
    $8.99
    downward going graph

    48.98%

    Downside

    1.47%

    Upside

    downward going graph

ImmuCell Corporation share price movements today

Previous Close
$8.72
Open
$8.72
Volume
240.0K
Day's Low - High
$8.72 - $8.96
52 Week Low - High
$4.52 - $8.99

ImmuCell Corporation Historical Returns

1 Month Return
+ 31.92 %
3 Month Return
+ 39.74 %
1 Year Return
+ 71.99 %
3 Year Return
+ 77.96 %
5 Year Return
-11.65 %

ImmuCell Corporation Stock Fundamentals & Key Indicators

Check ImmuCell Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$78.9M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

5.2M

Revenue (TTM)

27.6M

Profit Margin

-3.76%

Return On Equity TTM

-3.81%

ImmuCell Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ImmuCell Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ImmuCell Corporation image
ImmuCell Corporation
BUY$78.9M-11.65%NA-3.76%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B125.53%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B101.66%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B42.22%17.1229.65%

Stock Returns calculator for ImmuCell Corporation Stock including INR - Dollar returns

The ImmuCell Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

ImmuCell Corporation investment value today

Current value as on today

₹1,97,528

Returns

₹97,528

(+97.53%)

Returns from ImmuCell Corporation Stock

₹74,753 (+74.75%)

Dollar Impact

₹22,774 (+22.77%)

Analyst Recommendation on ImmuCell Corporation Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for ImmuCell Corporation. Average target price of $14

ImmuCell Corporation Share Price Target

Get share price movements and forecasts by analysts on ImmuCell Corporation.

What analysts predicted

36.71%UPSIDE

Target Price

$14

Current Price

$8.86

Analyzed by

7 Analysts

Target

$14.00

ImmuCell Corporation target price $14, a slight upside of 36.71% compared to current price of $8.86. According to 7 analysts rating.

ImmuCell Corporation Stock’s Investor Sentiment and Interest

Search interest for ImmuCell Corporation Stock has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:200% versus previous 30 day period

ImmuCell Corporation Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
5
7
5
6
7
8
6
5
7
Gross Profit
1
1
2
1
1
2
3
2
2
2
Operating Income
-1
-1
0
-1
0
0
1
0
0
0
EBITDA
0
0
0
0
0
1
1
1
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
0
-1
0
0
1
0
0
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
-1
0
-1
0
0
1
0
0
-2
Net Profit Margin
-17.42%
-22.37%
-6.03%
-27.99%
-11.67%
6.64%
17.94%
7.79%
-2.54%
-37.36%

ImmuCell Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
9
10
10
13
15
19
18
17
26
27
Gross Profit
5
5
5
6
6
8
7
4
7
11
Operating Income
0
0
-1
0
-1
0
-2
-5
-1
1
EBITDA
1
0
0
1
0
2
0
-2
1
4
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
0
1
2
2
2
2
2
2
2
Income Before Tax
0
0
-1
-1
-1
0
-2
-5
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
0
-2
-1
-1
0
-2
-5
-2
-1
Net Profit Margin
5.33%
-1.61%
-21.14%
-9.44%
-6.66%
-0.41%
-13.43%
-33.05%
-8.14%
-3.76%

ImmuCell Corporation Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
0
-1
0
0
1
0
0
-1
Operating Cash Flow
-
0
0
0
0
1
1
-1
0
Investing Cash Flow
-
0
0
0
0
0
0
0
0
Financing Cash Flow
-
0
0
3
0
0
0
0
0
Change in Cash
-
0
0
2
0
0
1
-2
0

ImmuCell Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Operating Cash Flow
1
0
0
1
0
-1
-4
0
2
Investing Cash Flow
-12
-1
-3
-2
-1
-3
-1
0
-1
Financing Cash Flow
9
0
6
1
3
1
1
2
-1
Change in Cash
-1
-1
3
0
3
-4
-4
2
0

Global Institutional Holdings in ImmuCell Corporation

Funds
Holdings
Cresset Asset Management, LLC
1.5%
Northern Trust Corp
0.42%
Morgan Stanley - Brokerage Accounts
1.38%
Steadtrust LLC
0.63%
Bleichroeder LP
1.12%
See all

ImmuCell Corporation News & Key Events

    Insights on ImmuCell Corporation

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, ICCC has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 5.50M → 7.62M (in $), with an average increase of 27.8% per quarter

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, ICCC has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, ICCC stock has moved up by 35.4%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, 1.44M → -2.84M (in $), with an average decrease of 710.6% per quarter

    About ImmuCell Corporation

    ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
    OrganisationImmuCell Corporation
    Headquarters56 Evergreen Drive, Portland, ME, United States, 04103
    IndustryBiotechnology
    CEOMr. Paul F. Olivier Te Boekhorst
    E-voting on sharesClick here to vote

    Key Management of ImmuCell Corporation

    Name

    Title

    Ms. Bobbi Jo Brockmann

    Senior Vice President of Sales & Marketing

    Ms. Elizabeth S. Toothaker

    Director of Finance & Administration and Controller

    Mr. A. Gustavo Scaffa

    Senior Director of Quality

    John W. Zinckgraf

    Director of Product Development

    Mr. Paul F. Olivier Te Boekhorst

    President, CEO & Director

    Mr. Timothy C. Fiori

    CFO, Secretary, Treasurer & Director

    FAQs

    What is ImmuCell Corporation share price today?

    ImmuCell Corporation share price today is $8.86 as on at the close of the market. ImmuCell Corporation share today touched a day high of $8.96 and a low of $8.72.

    What is the 52 week high and 52 week low for ImmuCell Corporation share?

    ImmuCell Corporation share touched a 52 week high of $8.99 on and a 52 week low of $4.52 on . ImmuCell Corporation stock price today i.e. is closed at $8.86,which is 1.45% down from its 52 week high and 96.02% up from its 52 week low.

    What is ImmuCell Corporation's market capitalisation today?

    ImmuCell Corporation market capitalisation is $0.00T as on .

    How to invest in ImmuCell Corporation Stock (ICCC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for ImmuCell Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ImmuCell Corporation Shares that will get you 0.1693 shares as per ImmuCell Corporation share price of $8.86 per share as on May 6, 2026 at 1:26 am IST.

    What is the minimum amount required to buy ImmuCell Corporation Stock (ICCC) from India?

    Indian investors can start investing in ImmuCell Corporation (ICCC) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹952.80 in ImmuCell Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on ImmuCell Corporation share’s latest price of $8.86 as on May 6, 2026 at 1:26 am IST, you will get 1.1287 shares of ImmuCell Corporation. Learn more about fractional shares .

    What are the returns that ImmuCell Corporation has given to Indian investors in the last 5 years?

    ImmuCell Corporation stock has given -11.65% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?